SAN DIEGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced the presentation of results from the Phase 1b study of nimacimab in subjects with metabolic-associated steatotic liver disease (MASLD) at the European Association for the Study of Diabetes (EASD) Annual Meeting. The study demonstrated that nimacimab was safe, well-tol ...

(TSX: DNTL), Canada's largest and one of North America's fastest growing networks of dental practices, declared a dividend and announced that it will release its third quarter 2025 financial results before the market open on November 6, 2025. Dividend The Company's Board of Directors has authorized a dividend of $0.025 per Subordinate Voting Share and Multiple Voting Share, payable on October 21, 2025 to sharehol. TORONTO--(BUSINESS WIRE)--dentalcorp Holdings Ltd. ("Dentalcorp†or the "Company†) ...

Goldmoney Inc. Announces Normal Course Issuer BidSeptember 19, 2025 7:00 AM EDT | Source: GoldMoney Inc.Tortola, British Virgin Islands--(Newsfile Corp. - September 19, 2025) - Goldmoney Inc. (TSX: XAU) (US: XAUMF) ("Goldmoney" or the "Company"), today announced acceptance by the Toronto Stock Exchange (the "TSX") of Goldmoney's Notice of Intention to make a normal course issuer bid (the "NCIB") to purchase for cancellation up to 777,262 common shares (the "Shares") of Goldmoney. The Shares re ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will host a webcast to review data from the successful TETON-2 pivotal study evaluating the use of nebulized Tyvaso® (treprostinil) Inhalation Solution for the treatment of idiopathic pulmonary fibrosis (IPF) on Sunday, September 28, 2025, at 12:30 p.m. Eastern Time. During the webcast, Steven D. Nathan, M.D., Schar Chair, Advanced Lung Disease and Lung Tran. ...

There was no obvious factor dragging prices lower, although investors may have been taking the chance to lock in some profit. ...

TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) is pleased to announce that the Ministry of Industrial Policy and Energy of Huelva, Andalusia has granted the Company exploration permits for the San Antonio and Terranova claims (collectively, the “New Properties”) (Figure 1). These New Properties add an additional 181 hectares to Emerita’s wholly owned Iberian Pyrite Belt holdings. The New Properties are adjacent to the Ib ...

FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the European Commission (EC) and Swiss Agency for Therapeutic Products, Swissmedic, have approved EKTERLY® (sebetralstat), a novel, oral plasma kallikrein inhibitor, for the symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older. EKTERLY is the first and only oral on-demand treatment for HAE in the European U. ...

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Acute Myeloid Leukemia were updated to include revumenib as a category 2A recommendation for relapsed or refractory (R/R) acute myeloid leukemia (AML) with an NPM1 mutation (mNPM1).1 The update was based on p ...

SmartAsset and Yahoo Finance LLC may earn commission or revenue through links in the content below. I currently have $680,000 in a 401(k), $150,000 in savings and a pension of $1,600 per month. Can I retire at age 62? – Hieu This is a good question and the answer depends primarily on what your expenses are and how much you will collect from Social Security. What we can do here is run the numbers on a few different scenarios to give you a sense of how much income you can expect to have and the level of mo ...

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Samsung Electronics, in collaboration with Niio, unveils Code of Nature — an immersive, generative digital art installation designed for The Wall LED display in the lobby of its Germany office in Eschborn. This striking installation transforms the space into a living canvas, reflecting Samsung’s commitment to innovation, culture, and its local presence. Created by renowned digital artist Ronen Tanchum of Phenomena Labs and curated with Niio — the global platform ...